---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-075549"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2023-09-11T23:59:59+00:00"
generated_at: "2026-06-10T21:40:30.886698+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Adial Pharmaceuticals to present at H.C. Wainwright conference; no material updates disclosed

## Summary
- Company will present at H.C. Wainwright 25th Annual Global Investment Conference Sept 11-13, 2023.
- Investor presentation furnished as Exhibit 99.1 contains no new financial or operational data.
- No earnings, guidance, or pipeline milestones announced in this filing.
- Filing is procedural under Regulation FD; presentation includes standard forward-looking statements.

## SEC filing metadata
- accession: 0001213900-23-075549
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2023-09-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390023075549/0001213900-23-075549-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390023075549/ea184974-8k_adialpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-075549
- JSON: https://secwatch.observer/filing/0001213900-23-075549.json
- Plain text: https://secwatch.observer/filing/0001213900-23-075549.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.